22 Juni 2020

Amyris Launches Safe Alternative To Talc-Based Baby Powder

Sales Significantly Exceeding Expectations

Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of “Baby Cream to Powder” under its Pipette™ baby brand giving caring parents more choice and keeping babies safe.

Baby Cream to PowderThis safe, talc-free alternative to baby powder goes on as an easy-to-apply cream to prevent and treat diaper rash and irritation and transforms into a silky powder on skin, eliminating the risk of powder inhalation. The announcement by Amyris comes on the heels of news that the largest and leading provider of baby care products will stop selling talcum-based baby powder in the U.S. and Canada amidst questions about its product safety.

The Pipette brand is quickly delivering to market innovative and effective products that are free of harmful ingredients. “Our Baby Cream to Powder addresses parents’ concerns by eliminating dust, mess and irritation commonly associated with traditional powders,” said Caroline Hadfield, President of Pipette.  “Our goal is to deliver innovative, best performing and safest, non-toxic alternative sustainable products that will help parents, babies, and families.”

As with all Pipette products, 100% sugarcane-derived squalane is a main ingredient in Baby Cream to Powder, offering weightless hydration for baby’s sensitive skin and antioxidant-rich mango seed butter helps restore the skin’s natural balance. The creamy format makes it easy to apply in those hard to reach baby rolls or along the diaper line.

Pipette’s Baby Cream to Powder is EWG (Environmental Working Group) Verified, Leaping Bunny Approved, dermatologist tested, pediatrician approved, hypoallergenic, nontoxic, vegan, and synthetic fragrance-free.

“Our Pipette and clean skincare consumer brands are experiencing very strong growth,” said John Melo, President and Chief Executive Officer. “Based on current demand, we believe the consumer business has the potential to reach over $90 million in revenue for 2020. Consumers are focusing on healthy skin for themselves and their family and have moved their purchasing online. Sugarcane derived squalane is now clinically proven to provide significant nourishment for the skin microbiome, and we are very pleased to meet a critical need for the consumer at a time when the skin needs it most.”

Source: Amyris, Inc., press release, 2020-05-21.

Supplier

Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email